Digital Health Strategy Monitor

September 2026 was the strongest month of 2026 for digital health dealmaking, and clearest confirmation the market has turned. US digital health funding reached $7.4B in H1 2026, with roughly $1.85B more across nine rounds in the last 30 days alone. Median deal size rose from $12M to $14M, and M&A captured 97.6% of exits.

Funding. EliseAI raised $350M at a $4B valuation and Heidi Health $340M at a $900M valuation — both AI workflow automation. Precision Neuroscience raised $250M for brain-computer interfaces. A distinct SMB health-benefits cluster emerged with Angle Health ($600M), Thatch ($108M) and Corridor ($25M). In Europe, Tandem Health raised $100M Series B led by the Scaleup Europe Fund, and Penelope Health €87M for payer and revenue-cycle automation.

M&A. Hinge Health acquired Cylinder Health for $105M, expanding from MSK into digestive health. DexCare acquired Mila Health, Medallion acquired Andros, Hello Patient acquired Converse Health.

Market access. DeepHealth received FDA clearance for Chest XRay, built on a foundation model — with its CE-marked version already analysing 2.8 million exams annually in Europe. The FDA released draft guidance on robotic surgical devices.

Urology — the month's standout. FemPulse secured CE Mark under EU MDR for the FemPulse Ring, a non-implanted, patient-managed vaginal neuromodulation device for overactive bladder in women, now EUDAMED-listed and supported by four clinical studies. It gives the 50+ million women in Europe with OAB a first-line non-invasive alternative to medication and implanted neurostimulators — and makes OAB a credible commercial target for bioelectronics. Clinical data follows at ICS on 9 October. Supporting news: SpaceOAR Flex Hydrogel FDA clearance for prostate radiotherapy, and PACE-A showing similar 8-year disease control for SBRT vs prostatectomy with lower urinary incontinence after SBRT.

The through-line: capital is concentrating in AI that removes real operational burden, while urology value creation sits in precision diagnostics, digital pathology and now bioelectronics.

Download the full September 2026 report for the complete deal list, regulatory detail and urology deep-dive.

Here are previous Digital Health Strategy monitors you can read:

Download the full August 2026 report for the complete deal list, regulatory detail and urology deep-dive.

Download the full July 2026 report for the complete deal list, regulatory detail and urology deep-dive.

Download the full June 2026 report for the complete deal list, regulatory detail, urology deep-dive and outlook into Q3.

Download the full May report for the complete deal list, regulatory detail, and outlook into June 2026. 

Download the full April report for the complete deal list, regulatory detail, and outlook.